Advertisement

Experientia

, Volume 29, Issue 11, pp 1402–1403 | Cite as

Stabilizing effect of anti-normal erythrocyte catalase antibody on the labile catalase variant present in Swiss-type acatalasemia

  • E. Shapira
  • Y. Ben-Yoseph
  • H. Aebi
Specialia

Keywords

Catalase Erythrocyte Catalase Catalase Antibody 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Zusammenfassung

Die instabile Katalase-Variante, welche in den Erythrocyten des Akatalasie-Falles A.B. vorkommt, lässt sich in vitro durch Zusatz von Anti-Katalase IgG-Fraktion oder von Fab-Fragmenten ohne Aktivitätseinbusse stabilisieren. Es wird angenommen, dass dies auf eine Fixierung der aktiven Konformation des Enzyms zurückzuführen ist.

Literatur

  1. 1.
    S. Matsubara, H. Suter andH. Aebi, Humangenetik4, 29 (1967).Google Scholar
  2. 2.
    H. Aebi andH. Suter, Adv human Genet.2, 143 (1971).Google Scholar
  3. 3.
    E. Shapira, Y. Ben-Yoseph andH. Aebi, Enzyme, in press.Google Scholar
  4. 4.
    N. Zyk andN. Citri, Biochim. biophys. Acta159, 317 (1968).PubMedGoogle Scholar
  5. 5.
    D. Michaeli, J. D. Pinto, E. Benjamini andF. P. de Buren, Immunochemistry6, 101 371 (1969).PubMedGoogle Scholar
  6. 6.
    F. Melchers, G. Köhler andW. Messner, inProtein-Protein Interactions (Eds.R. Jaenicke andE. Helmreich; Springer-Verlag, Berlin, Heidelberg, New York 1972), p. 409.Google Scholar
  7. 7.
    F. Celada, J. Ellis, K. Bodlund andB. Rotman; J. exp. Med.134, 751 (1971).PubMedGoogle Scholar
  8. 8.
    R. N. Feinstein, B. N. Jaroslow, J. B. Howard andJ. T. Faulhaber, J. Immun.106, 1316 (1971).PubMedGoogle Scholar
  9. 9.
    R. N. Feinstein, B. N. Jaroslow andJ. B. Howard, Proc. Soc. exp. Biol. and Med.139, 597 (1972).Google Scholar
  10. 10.
    Y. Ben-Yoseph andE. Shapira, J. Lab. clin. Med.81, 133 (1973).PubMedGoogle Scholar
  11. 11.
    J. J. Cebra, D. Givol, H. I. Silman andE. Katchalski, J. biol. Chem.236, 1720 (1961).PubMedGoogle Scholar
  12. 12.
    R. Axen, J. Porath andS. Ernback, Nature, Lond.214, 1302 (1967).Google Scholar
  13. 13.
    R. R. Porter, Biochem. J.66, 677 (1957).PubMedGoogle Scholar
  14. 14.
    E. A. Kabat andM. M. Mayer, inExperimental immunochemistry (C. Charles Thomas Publisher, Springfield Ill. 1961).Google Scholar
  15. 15.
    H. Aebi andH. Suter,Catalase in Biochemiscal Methods in Red Cell Genetics (Ed. J. J. Junis; Academic Press, New York 1969), p. 255.Google Scholar
  16. 16.
    Y. Ben-Yoseph, Ph. D. Thesis, submitted to the Hebrew University of Jerusalem, 1973.Google Scholar
  17. 17.
    R. N. Feinstein,Studies of Acatalasemia; in Birth Defects, Original Article Series, Vol. 9, No. 2; March 1973 (The National Foundation March of Dimes; The Williams and Wilkins Co., Baltimore).Google Scholar
  18. 18.
    Acknowledgments. The financial support of the ‘Roche’-Studienstiftung to one of the authors (E.S.) is gratefully acknowledged.Google Scholar

Copyright information

© Birkhäuser Verlag 1973

Authors and Affiliations

  • E. Shapira
    • 1
    • 2
  • Y. Ben-Yoseph
    • 1
    • 2
  • H. Aebi
    • 1
    • 2
  1. 1.Medizinisch-chemisches Institut der UniversitätBern 9Switzerland
  2. 2.Department of Pediatrics and Child Care, Pediatric Research Unit Hadassah University Hospital Medical SchoolHebrew UniversityJerusalemIsrael

Personalised recommendations